newsfilter
← Latest News
Business Wire·

DiaMedica Therapeutics Appoints Daniel J. O'Connor to the Board of Directors

DiaMedica Therapeutics Inc. (NASDAQ:DMAC), a clinical-stage biopharmaceutical company focused on acute ischemic stroke and preeclampsia, today announced the election of Daniel J. O'Connor to its Board of Directors,